|Join our Panel of World-Class Experts to Explore New Horizons
in Childhood Brain Tumor Research and Treatment
on December 17 at 2pm/EST to Watch LIVE
A recent study published in Cell, exploring the "proteogenomics" -- the proteins, genes, and RNA transcription -- involved in pediatric brain tumors, has generated a more complete understanding of these tumors and could help physicians more accurately identify different types of tumors and better methods for treating them in children and young adults.
The study was conducted by a team of investigators from the Children's Brain Tumor Network (CBTN) and the National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium (CPTAC).
Join us live on Facebook for an hour-long panel discussion with these CBTN and CPTAC experts to explore their landmark study, and hear how these insights could change the treatment landscape for countless children around the world.
While watching, you can submit Facebook comments and questions for our moderator to share with our panel of guests! If you have advance questions or comments, send them in to us at firstname.lastname@example.org!
- Amanda Paulovich, MD, PhD
Professor, Clinical Research Division; Fred Hutchinson Cancer Research Center
- Francesca Petralia, PhD
Assistant Professor, Genetics and Genomic Sciences; Icahn School of Medicine, Mt. Sinai
- Adam Resnick, PhD
Scientific Co-Chair; CBTN
Director, Center for Data Driven Discovery in Biomedicine; Children's Hospital of Philadelphia
- Henry Rodriguez, PhD, MS, MBA
Director, Office of Cancer Clinical Proteomics Research; National Cancer Institute
- Brian Rood, MD
Executive Co-Chair; CBTN
Director, Clinical Neuro-Oncology; Medical Director, Brain Tumor Institute; Children’s National Health System
- Pei Wang, PhD
Professor, Genetics and Genomic Sciences; Icahn School of Medicine, Mt. Sinai
We Hope You'll Join Us!